Cargando…

Aberrant expression of glycogen synthase kinase-3β in human breast and head and neck cancer

Glycogen Synthase Kinase-3β (GSK-3β), a serine/threonine protein kinase, has been implicated as a potential therapeutic target in human cancer. The objective of the present study was to evaluate aberrant expression of GSK-3β as a potential biomarker in human breast and head and neck cancers. Nuclear...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ugolkov, Andrey V., Matsangou, Maria, Taxter, Timothy J., O'Halloran, Thomas V., Cryns, Vincent L., Giles, Francis J., Mazar, Andrew P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202539/ https://www.ncbi.nlm.nih.gov/pubmed/30405781 http://dx.doi.org/10.3892/ol.2018.9483

Ejemplares similares

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer
por: Fu, Yunfeng, et al.
Publicado: (2014)

Aberrant spindle dynamics and cytokinesis in Dictyostelium discoideum cells that lack glycogen synthase kinase 3()
por: Harwood, Adrian J., et al.
Publicado: (2013)

Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors()
por: Bondarenko, Gennadiy, et al.
Publicado: (2015)

Glycogen Synthase Kinase-3 Is Required for Efficient Dictyostelium Chemotaxis
por: Teo, Regina, et al.
Publicado: (2010)

Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
por: Kitano, Ayako, et al.
Publicado: (2013)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis
por: Jeffers, Ann, et al.
Publicado: (2019)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

GSK-3β inhibitor, 9-ING-41, reduces cell viability and halts proliferation of B-cell lymphoma cell lines as a single agent and in combination with novel agents
por: Karmali, Reem, et al.
Publicado: (2017)

Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3
por: Kanzariya, Nilesh R., et al.
Publicado: (2011)

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
por: Jope, Richard Scott
Publicado: (2011)

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
por: Polter, Abigail M., et al.
Publicado: (2011)

The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
por: Marosi, Mate, et al.
Publicado: (2022)

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
por: Yu, Honglu, et al.
Publicado: (2023)

Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models()()
por: Ugolkov, Andrey, et al.
Publicado: (2017)

A Crosstalk between the Biorhythms and Gatekeepers of Longevity: Dual Role of Glycogen Synthase Kinase-3
por: Shilovsky, Gregory A., et al.
Publicado: (2021)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

ERK-regulated αB-Crystallin Induction by Matrix Detachment Inhibits Anoikis and Promotes Lung Metastasis in vivo
por: Malin, Dmitry, et al.
Publicado: (2015)

Clinically relevant GSK-3β inhibitor 9-ING-41 is active as a single agent and in combination with other antitumor therapies in human renal cancer
por: Anraku, Tsutomu, et al.
Publicado: (2020)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer
por: Elmadbouh, Omer H. M., et al.
Publicado: (2022)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
por: Bilim, V, et al.
Publicado: (2009)

Identification of a New Epitope in uPAR as a Target for the Cancer Therapeutic Monoclonal Antibody ATN-658, a Structural Homolog of the uPAR Binding Integrin CD11b (αM)
por: Xu, Xiang, et al.
Publicado: (2014)

Functional Implications of Glycogen Synthase Kinase-3-Mediated Tau Phosphorylation
por: Hanger, Diane P., et al.
Publicado: (2011)

Regulation by Glycogen Synthase Kinase-3 of Inflammation and T Cells in CNS Diseases
por: Beurel, Eléonore
Publicado: (2011)

Emerging Roles of Glycogen Synthase Kinase 3 in the Treatment of Brain Tumors
por: Mills, Caroline N., et al.
Publicado: (2011)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging
por: Pandey, Mukesh K., et al.
Publicado: (2016)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

Phylogenetic diversification of glycogen synthase kinase 3/SHAGGY-like kinase genes in plants
por: Yoo, Mi-Jeong, et al.
Publicado: (2006)

Identification and characterization of two wheat Glycogen Synthase Kinase 3/ SHAGGY-like kinases
por: Bittner, Thomas, et al.
Publicado: (2013)

Allosteric Regulation of Glycogen Synthase Kinase 3β: A Theoretical Study
por: Buch, Idit, et al.
Publicado: (2010)

Glycogen synthase kinase 3β represses MYOGENIN function in alveolar rhabdomyosarcoma
por: Dionyssiou, M G, et al.
Publicado: (2014)

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer
por: Kuroki, Hiroo, et al.
Publicado: (2019)

Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis
por: Dembowy, J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eu1lj483tumglfr8dfkr58c0sd